Pulse Biosciences touts positive results from PFA early feasibility study

Pulse Biosciences touts positive results from PFA early feasibility study

Source: 
Clinical Trials Arena
snippet: 

Already cleared in the US for use in soft tissue ablation, Pulse Biosciences is looking to add AF to CellFX’s indication list.